Le Lézard
Classified in: Health
Subjects: HEALTH, LIFESTYLE, TRADE SHOWS/SEMINARS/WEBINARS

"The father of the legal industry," Steve DeAngelo, to be inducted into the Hall of Fame at O'Cannabiz Awards at Casa Loma, June 1, 2022


Toronto, Ontario, May 26, 2022 (GLOBE NEWSWIRE) -- When Yippie activists held their annual Smoke-Ins in Washington, D.C. in the ?70s, Steve DeAngelo was a key organizer. In 2019, when pot was legal almost everywhere, but people still languished in jail for it, DeAngelo took up their cause with his Last Prisoner Project.

In between, Steve DeAngelo's life was one cannabis cause after another. He's been a businessman (multiple enterprises, including Harborside, one of the first six dispensaries licensed in the U.S., and among the first to feature a drive-thru), an author (The Cannabis Manifesto) and a passionate champion of political initiatives (including Initiative 59, Washington D.C.'s medical cannabis law and Prop 64, California's adult-use law).

For these reasons and many more, DeAngelo is being given a Lifetime Achievement Award and inducted into the Hall of Fame at the O'Cannabiz Awards at Casa Loma, June 1, 2022. The awards - which are also honouring legendary comedian Tommy Chong and industry elite - are a celebratory launch event for the O'Cannabiz Conference and Expo, which takes place at the International Centre June 1-3, 2022.

DeAngelo, who's been dubbed "The father of the legal industry," will also be a Keynote Speaker at the conference. Other honorifics attached to his name include "Gatekeeper of the Industry" (International Business Times) and one of the seven Most Powerful People in America's cannabis industry (Fortune).

"Ironically, what was once called ?the Devil's weed,' has inspired its share of angels," says O'Cannabiz president Neill Dixon. "And Steve DeAngelo was obviously put here to do good, not just pushing for a legal cannabis industry, but an ethical, healthful and politically engaged one. I can't think of a more positive and impactful person to enshrine in our Hall of Fame."

ABOUT O'CANNABIZ CONFERENCE & EXPO:

Voted the No. 1 Cannabis Event in Canada by High Canada Magazine, O'Cannabiz is known for its ability to showcase and promote the people, businesses and brands that are making a difference as cannabis continues its path toward global acceptance. Many of these visionaries will be celebrated during the 2nd Annual O'Cannabiz Industry Awards Gala, slated for the evening of Wednesday, June 1st, 2022 at the majestic Casa Loma castle located in midtown Toronto.

The producers of O'Cannabiz have decades of experience producing national profile events and creating global connections between business communities in the arts, broadcasting, media, and technology. They have organized trade summit initiatives with governments around the world and have worked closely with sponsors at all levels of the Canadian government.

To learn more about the O'Cannabiz Conference and Expo, including how to purchase tickets, become a sponsor or reserve a booth, visit: https://ocannabiz.com/ Connect on social media via Twitter: https://twitter.com/OCannabiz

 

-30- 



These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: